Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$1.31B
Total Bought:
$181.35M
Total Sold:
$398.74M
Net Transaction:
-$217.38M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Heartflow, Inc.(HTFL)12,448,15812,448,1580$419.00M$362.86M27.79%-$56.14M
Newamsterdam Pharma Company
ORDINARY SHARES
10,719,1107,306,566-3,412,544$304.85M$256.31M19.63%-$48.54M
Olema Pharmaceuticals, Inc.(OLMA)6,843,9548,508,641+1,664,687$67.00M$212.72M16.29%+$145.71M
Savara Inc.(SVRA)17,600,62117,600,6210$62.83M$106.13M8.13%+$43.30M
Pharvaris N V
COM
3,181,2752,802,081-379,194$79.37M$77.76M5.96%-$1.62M
Solid Biosciences Inc7,911,6697,911,6690$48.81M$44.62M3.42%-$4.19M
Upstream Bio, Inc.(UPB)2,439,5381,329,544-1,109,994$45.89M$36.10M2.76%-$9.79M
X4 Pharmaceuticals, Inc.(XFOR)2,436,5887,967,454+5,530,866$8.33M$31.87M2.44%+$23.54M
Dianthus Therapeutics, Inc.(DNTH)1,315,892743,592-572,300$51.78M$30.64M2.35%-$21.14M
Kyverna Therapeutics, Inc.(KYTX)3,368,3703,110,000-258,370$20.21M$29.23M2.24%+$9.02M
Annexon, Inc.(ANNX)5,249,0695,249,0690$16.01M$26.35M2.02%+$10.34M
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$28.17M$24.46M1.87%-$3.71M
Cabaletta Bio, Inc.(CABA)9,677,1259,677,1250$22.64M$21.19M1.62%-$1.45M
C4 Therapeutics, Inc.(CCCC)1,111,9107,171,910+6,060,000$2.47M$13.70M1.05%+$11.23M
Mersana Therapeutics Inc346,545346,5450$2.69M$10.03M0.77%+$7.34M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$7.21M$8.87M0.68%+$1.67M
Tango Therapeutics, Inc.(TNGX)2,712,008653,493-2,058,515$22.78M$5.79M0.44%-$16.99M
Xilio Therapeutics, Inc.(XLO)4,566,8177,372,686+2,805,869$3.85M$4.72M0.36%+$871.5K
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
100,00099,999-1$1.71M$2.30M0.18%+$589.0K
Century Therapeutics, Inc.(IPSC)3,538,6090-3,538,609$1.76M$0—-$1.76M
Cidara Therapeutics Inc3,020,9900-3,020,990$289.29M$0—-$289.29M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q4 2025 | TickerTrail